Viewing Study NCT01667133

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-03-03 @ 4:03 PM
Study NCT ID: NCT01667133
Status: COMPLETED
Last Update Posted: 2022-06-13
First Post: 2012-08-13
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)
Sponsor: Ariad Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myeloid Leukemia (CML) View
None Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Leukemia View
None Leukemia, Myeloid View
None Leukemia, Myelogenous, Chronic, BCR-ABL Positive View
None Neoplasms by Histologic Type View
None Neoplasms View
None Lymphoproliferative Disorders View
None Lymphatic Diseases View
None Immunoproliferative Disorders View
None Immune System Diseases View
None Myeloproliferative Disorders View
None Bone Marrow Diseases View
None Hematologic Diseases View